Gplaco Solutions - AI/ML enabled services

Gplaco Solutions - AI/ML enabled services

Share

Like and follow us for updates on the industry, jobs and career opportunities!!

05/01/2026

πŸŽ‰ New Year New Learning 🎈 New Opportunities 🎊

GPLACO SOLUTIONS brings you a high-impact, real-world training program on:

How to perform - Signal Detection & Management for the US, UK & EU?

An online training paid session for - MAHs / Sponsors, CROs, and Solution Providers!

What does the Program include?
βœ”οΈ End-to-end Signal Detection – step-by-step practical ex*****on
βœ”οΈ Signal validation, analysis, and prioritization using real examples
βœ”οΈ FDA & EMA signal tracking – how it is actually done in practice
βœ”οΈ Action planning, decision-making, and signal closure
βœ”οΈ Implementation of SOPs and Work Instructions (WIs)
βœ”οΈ Practical training models for signal management teams
βœ”οΈ Establishing and operating an effective Safety Data Monitoring Board (SDMB)

Program Details:
πŸ“… Dates: 28 & 29 January
⏰ Time: 7:00 to 8.30 PM IST (90 Minutes)
πŸ•’ Duration: For 2 Days

Last date to Register and complete the payment - 15 Jan 2026!

Photos from Gplaco Solutions - AI/ML enabled services's post 31/10/2025

πŸ’₯ ATTENTION PV & Regulatory Professionals: πŸ‘‡πŸ‘‡

Are you still relying on outdated frameworks for compliance and leadership?
The landscape of Pharmacovigilance (PV) and Regulatory Compliance is evolving faster than ever.

To stay audit-ready and advance your career, you need mastery in both technical ex*****on and strategic leadership.

πŸ’‘ Introducing the 2026 (JAN-MAR) Global Professional Development Series:

Technical Vs Leadership programs πŸ˜‡

We’ve distilled the most critical, audit-proven knowledge into two specialized tracks β€” designed to empower professionals across the US, UK, EU, and India. All are online/remote and paid sessions.

1️⃣ TECHNICAL TRACKS: Master the Core (Min 3 to 5yrs exp in ICSRs required)
Develop the skills for flawless compliance ex*****on β€” from SOPs, SDEAs, DSURs, Signal Management, RMPs to PSMF readiness.

2️⃣ LEADERSHIP TRACKS: Drive Strategic Governance (Managers and above only)
Elevate your leadership edge with QMS implementation, vendor oversight, governance, and GVP audit preparedness.

🌍 Global Schedule
US: Tuesdays & Thursdays, 9:30–11:00 AM EST
EU: Tuesdays & Thursdays, 3:30–5:00 PM CET
India: Tuesdays & Thursdays, 7:00–8:30 PM IST

πŸš€ Ready to lead your team to audit success?

View the full program outline and register today only by emailing:
πŸ“§ [email protected]

The details about the sessions and fees will be shared by email.

#SDEA #PVA #Pharmacovigilance for the US & EU Agreements 11/08/2025

βœ… SDEA and PVAs: Insights & Practical TakeawaysπŸ‘‡πŸ‘‡

Our recent training session on Safety Data Exchange Agreements (SDEA) and Pharmacovigilance Agreements (PVAs) was a great success! 🎯

πŸ“Œ Missed it?

Watch the video to gain valuable content, interview preparation tips, and real-world ex*****on insights.

πŸ’¬ Comment below the video on which topic you’d like us to cover next in our upcoming videos!😊

https://youtu.be/xn5viWvGqpY

#SDEA #PVA #Pharmacovigilance for the US & EU Agreements Interview preparation on Safety Data Exchange Agreements (SDEA) & Pharmacovigilance Agreements (PVAs) for the EU & US. Learn about the details of the agreeme...

26/02/2025

Post 6: πŸ“ŒICSR Case Narrative Writing: Is it an art?

- Initially yes, but after a little bit of practice it is quite easy!!

Interview question - How do you write narrative?
❌ - I just follow the client/customer template
βœ… Talk about the chronology, history, event term, product and outcome

What are the best practices, common mistakes & key takeaways πŸ‘‡πŸ‘‡
βœ” Maintain a clear, structured format in case narratives

βœ” Ensure clinical accuracy by verifying information against source documents
βœ” Avoid copy-pasting to minimize oversight errors
βœ” Conduct thorough quality checks to catch inconsistencies or missing details
βœ” Ensure MedDRA coding consistency for adverse event descriptions
βœ” Train teams to write concise but comprehensive narratives that meet FDA/EMA expectations
βœ” Standardize global narrative writing SOPs to align with FDA, EMA, and MHRA requirements